美容醫學市場規模、佔有率和成長分析：按產品、治療方法、最終用戶和地區分類 - 行業預測，2024-2031

2022年全球美容醫學市場規模將為131億美元，從2023年的144億美元成長到2031年的356億美元，預測期內（2024-2031年）複合年成長率為10.1%。

由於提供的產品和服務範圍廣泛，美容市場正在經歷顯著成長。這種快速成長的背後是社會對外表的日益重視以及對美容治療的日益接受。醫療技術的創新為那些對傳統整容手術猶豫不決的人們提供了新的選擇，並有助於擴大市場。美容醫學目前包括合法治療，如抽脂、隆乳、肉毒桿菌注射、填充劑、雷射換膚和除毛療程。此外，該市場還包括護膚、化妝品、護髮等美容產品。對外觀的關注導致侵入性和微創手術的普及。社群媒體和影響者進一步放大了對美感提升的需求，尤其是在年輕族群中。時尚產業也發揮著重要作用，為那些為了自尊、社會接受或個人卓越而尋求改善外表的個人提供了便利。隨著科技的進步和自我護理意識的增強，全球對美容護理和產品的需求不斷增加。生活方式的改變，包括肥胖的增加，正在影響老年人口並促進市場成長。這一市場擴張的主要驅動力包括美學意識和需求的提高、許多手術是微創的、減少美容治療的禁忌以及增加可支配收入，尤其是在新興市場。這些因素預計將支持美容市場的持續成長。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 次要/一級資訊來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 技術分析
• 價格分析
• 價值鏈分析
• 市場生態系統
• Start-Ups分析
• 案例研究分析
• 貿易分析
• 專利分析
• 供應鏈分析
• 監管環境
• 創新矩陣
• 重點投資分析
• 關鍵成功因素
• 市場魅力指數
• 競爭程度

美容醫學市場：依產品

• 市場概況
• 臉部美容產品
  • 肉毒桿菌毒素
  • 真皮填充劑
  • 微晶換膚產品
  • 化學換膚
• 美容植入
  • 乳房植入
    • 矽膠乳房植入
    • 生理食鹽水乳房植入
  • 臀部植入
  • 臉部植入
• 皮膚美容儀器
  • 非手術緊膚裝置
  • 雷射皮膚修復儀
  • 微針產品
  • 照光治療儀
• 體型雕塑儀
  • 非手術減脂裝置
  • 脂肪團去除裝置
  • 抽脂裝置
• 醫生開出的化妝品和皮膚美白劑
• 拔毛
  • 雷射除毛儀
  • IPL除毛儀
• 紋身去除裝置
• 埋線拉提產品
• 醫生處方的睫毛產品
• 雷射指甲治療儀

美容醫學市場：依治療方法分類

• 市場概況
• 外科手術
  • 隆乳手術
  • 鼻整形術
  • 拉皮/身體提升
  • 其他
• 非手術治療
  • 抗老/活膚
  • 紋身/疤痕去除
  • 除毛
  • 脂肪分解
  • 其他

美容醫學市場：依最終用戶分類

• 市場概況
• 診所、醫院、醫療設施、水療中心
• 美容中心
• 居家醫療

美容醫學市場規模：按地區分類

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 英國
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• Lutronic（South Korea）
• Vennus Concept（Canada）
• Evolus Inc.（US）
• Cutera（US）
• Eclipse（Belgium）
• Cynosure（US）
• Merz Pharma（Germany）
• Sisram Medical Ltd（Israel）
• BTL Group of Companies（Switzerland）
• Zimmer Biomet（Poland）
• Fotona（US）
• Abbvie Inc.（US）
• Johnson & Johnson（US）
• Bausch Health Companies Inc.（Canada）
• Cutera（US）
• El.En. SPA（Italy）
• Inmode Ltd.（Israel）
• Fotona（Slovenia）
• Merz Pharma（Germany）
• Venus Concept（Canada）
• Aerolase Corp.（US）
• Sciton（US）
• Bohus Biotech Ab（Sweden）
• Lutronic（South Korea）
• Recosmo（South Korea）
• Sharplight Technologies Inc.（Canada）
• Therapeutics, Inc.（US）
• Medytox（South Korea）
• Polytech Health & Aesthetics Gmbh（Germany）
• Asclepion（Germany）
• Apyx Medical（US）
• Gc Aesthetics（Ireland）
• Laser Llc（Russia）
• Huadong Medicine Co., Ltd.（China）
• Revance Aesthetics（US）

Global Medical Aesthetics Market size was valued at USD 13.1 billion in 2022 and is poised to grow from USD 14.4 billion in 2023 to USD 35.6 billion by 2031, growing at a CAGR of 10.1% in the forecast period (2024-2031).

The aesthetic market is experiencing significant growth due to the broad array of products and services available. This surge is driven by the increasing societal emphasis on physical appearance and the growing acceptance of cosmetic treatments. Medical innovations are offering new options for those who may be hesitant about traditional cosmetic surgeries, thus propelling market expansion. Aesthetic medical procedures now include legally performed treatments such as liposuction, breast augmentation, Botox injections, fillers, laser peels, and hair removal therapies. Additionally, the market encompasses beauty products like skincare, cosmetics, and haircare. The focus on physical appearance has led to a rise in the popularity of invasive and minimally invasive procedures. Social media and influencers have further amplified the demand for aesthetic enhancements, particularly among younger demographics. The fashion industry also plays a significant role by catering to individuals seeking to improve their appearance for self-esteem, social acceptance, or personal excellence. As technology advances and awareness of self-care grows, the global demand for aesthetic treatments and products continues to rise. Lifestyle changes, including increased obesity, are impacting older adults and contributing to market growth. Key drivers of this expansion include heightened awareness and demand for aesthetic beauty, the minimally invasive nature of many procedures, reduced taboos surrounding cosmetic treatments, and rising disposable incomes, particularly in emerging markets. These factors are expected to support the continued growth of the aesthetic market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Medical Aesthetics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Medical Aesthetics Market Segmental Analysis

Global medical aesthetics market is segmented based on the Product, Procedure, End-user, and Region. Based on Product, the market is segmented into Facial Aesthetic Products (Botulinum Toxin, Dermal Fillers, Microdermabrasion Products, Chemicals Peels), Cosmetics Implants (Breast Implants {Silicone Breast Implants, Saline Breast Implants}, Gluteal Implants, Facial Implants), Skin Aesthetic Devices (Nonsurgical Skin Tightening Devices, Laser Skin Resurfacing Devices, Micro Needling Products, Light Therapy Devices), Body Contouring Devices (Nonsurgical Fat Reduction Devices, Cellulite Reduction Devices, Liposuctions Devices), Physician-dispensed Cosmeceuticals and Skin Lighteners, Hair Removal Devices (Laser Hair Removal Devices, IPL Hair Removal Devices), Tattoo Removal Devices, Thread Lift Products, Physician- Dispensed Eyelash Products, and Nail Treatment Laser Devices. Based on Procedure, the market is segmented into Surgical Procedures (Breast Augmentation, Rhinoplasty, Facelift and Body Lift, Others), Non-surgical Procedures (Anti-aging And Skin Rejuvenation, Tattoo and Scar Removal, Hair Removal, Lypolysis, and Others. Based on End-user, the market is segmented into Clinics, Hospitals, and Medicals Spas, Beauty Centers, and Home Care Settings. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa.

Drivers of the Global Medical Aesthetics Market

The cosmetic market is witnessing a significant shift towards proactive aesthetic procedures, with individuals increasingly seeking preventive treatments to maintain their youthful appearance rather than waiting until signs of aging become apparent. This trend reflects a millennial approach to self-care, focusing on maintaining a consistent appearance over time. Additionally, there is a growing emphasis on personalized treatments tailored to individual needs and preferences. This customization enhances the patient experience and fosters a stronger connection between clients and spas. As a result, customers are more likely to return, and offering a range of beauty-positive practices becomes crucial for attracting and retaining clients.

Restraints in the Global Medical Aesthetics Market

The regulatory landscape for equipment, procedures, and techniques aimed at preventing or treating diseases is complex and varies significantly across countries. This complexity creates obstacles for the introduction of innovative products and restricts market access for some providers. Navigating different regulatory regimes is challenging, requiring considerable time, resources, and expertise, which can impact the overall healthcare delivery system when introducing new treatments or devices. Additionally, stringent regulatory policies can pose significant barriers for smaller providers and manufacturers, limiting their ability to compete effectively. Consequently, regulatory instability can hinder technological innovation and delay the availability of advanced therapeutic procedures in various regions.

Market Trends of the Global Medical Aesthetics Market

Nonsurgical facial rejuvenation methods, such as botulinum toxin and hyaluronic acid treatments, are gaining popularity globally, contributing to market growth. Individuals with darker skin types often seek alternative medical procedures to achieve a lighter complexion, a trend particularly evident in countries like India, where darker skin tones are common. This ongoing demand supports the growth of such procedures. Additionally, glutathione, once celebrated in countries like the Philippines as a "magical skin whitening" molecule, has gained significant popularity worldwide. Despite some controversy, glutathione therapy for skin whitening is increasingly offered in aesthetic clinics across India, with many now providing IV-based glutathione treatments.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Value Chain Analysis
• Ecosystem of the Market
• Start-up Analysis
• Case Study Analysis
• Trade Analysis
• Patent Analysis
• Supply Chain Analysis
• Regulatory Landscape
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Market Attractive Index
• Degree of Competition

Medical Aesthetics Market by Product

• Market Overview
• Facial Aesthetic Products
  • Botulinum Toxin
  • Dermal Fillers
  • Microdermabrasion Products
  • Chemicals Peels
• Cosmetics Implants
  • Breast Implants
    • Silicone Breast Implants
    • Saline Breast Implants
  • Gluteal Implants
  • Facial Implants
• Skin Aesthetic Devices
  • Nonsurgical Skin Tightening Devices
  • Laser Skin Resurfacing Devices
  • Micro Needling Products
  • Light Therapy Devices
• Body Contouring Devices
  • Nonsurgical Fat Reduction Devices
  • Cellulite Reduction Devices
  • Liposuctions Devices
• Physician-dispensed Cosmeceuticals and Skin Lighteners
• Hair Removal Devices
  • Laser Hair Removal Devices
  • IPL Hair Removal Devices
• Tattoo Removal Devices
• Thread Lift Products
• Physician- Dispensed Eyelash Products
• Nail Treatment Laser Devices

Medical Aesthetics Market by Procedure

• Market Overview
• Surgical Procedures
  • Breast Augmentation
  • Rhinoplasty
  • Facelift and Body Lift
  • Others
• Non-surgical Procedures
  • Anti-aging And Skin Rejuvenation
  • Tattoo and Scar Removal
  • Hair Removal
  • Lypolysis
  • Others

Medical Aesthetics Market by End-user

• Market Overview
• Clinics, Hospitals, and Medicals Spas
• Beauty Centers
• Home Care Settings

Medical Aesthetics Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • Italy
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Lutronic (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vennus Concept (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evolus Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cutera (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eclipse (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cynosure (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merz Pharma (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sisram Medical Ltd (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BTL Group of Companies (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet (Poland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fotona (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbvie Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch Health Companies Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cutera (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• El.En. S.P.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inmode Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fotona (Slovenia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merz Pharma (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Venus Concept (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aerolase Corp. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sciton (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bohus Biotech Ab (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lutronic (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Recosmo (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sharplight Technologies Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Therapeutics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medytox (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Polytech Health & Aesthetics Gmbh (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asclepion (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Apyx Medical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gc Aesthetics (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laser Llc (Russia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Huadong Medicine Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revance Aesthetics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments